Get started
Author

Rosa Lauppe

Observed names: Lauppe, Rosa, R Lauppe, R. Lauppe, Rosa Elisabeth Lauppe
Observed institution: Quantify Research (Sweden)
ORCID: 0000-0002-5776-6600
Observed ORCID: 0000-0002-5776-6600
OpenAlex ID: A5025293135
Prevalence, Characteristics, and Mortality of Patients with Transthyretin Amyloid Cardiomyopathy in the Nordic Countries
2022 · Rosa Lauppe, Johan Liseth Hansen, et al. · ESC Heart Failure · 51
PDF
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
2021 · Rosa Elisabeth Lauppe, Johan Liseth Hansen, et al. · Open Heart · 50
PDF
Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
2021 · Jordi Bover, Joel Gunnarsson, et al. · Clinical Kidney Journal · 43
PDF
Real-world effectiveness of osteoporosis treatment in the oldest old
2020 · O. Ström, R. Lauppe, et al. · Osteoporosis International · 33
PDF
Healthcare Resource Use of Patients with Transthyretin Amyloid Cardiomyopathy
2022 · Rosa Lauppe, Johan Liseth Hansen, et al. · ESC Heart Failure · 16
Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic population
2019 · Rosa Lauppe, Kristina E. Åkesson, et al. · Archives of Osteoporosis · 6
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study
2022 · Rosa Lauppe, Fredrik O. L. Nilsson, et al. · Acta Oncologica · 5
P0891meta-analysis of Nutritional Vitamin D for the Treatment of Secondary Hyperparathyroidism in Patients With Non-dialysis Chronic Kidney Disease
2020 · Joel Gunnarsson, Rosa Lauppe, et al. · Nephrology Dialysis Transplantation · 1
PDF
Abstract PO4-17-04: CDK 4/6 inhibitor switching patterns in Swedish patients with metastatic breast cancer: 5-year update from the SIRI study
2024 · Henrik Lindman, Antonis Valachis, et al. · Cancer Research
428P Palbociclib dose patterns in Swedish patients with metastatic breast cancer: 5-year update from the SIRI study
2023 · A. Valachis, H. Lindman, et al. · Annals of Oncology
PDF
HTA82 Health Technology Assessment of Hospital Medicines in Denmark: A Review of DMC Decisions (2017-2022)
2022 · J Viollet, E O'Leary, et al. · Value in Health
PDF
POSB112 Health Care Resource Use of Transthyretin Amyloid Cardiomyopathy in Sweden
2022 · R Lauppe, J Liseth Hansen, et al. · Value in Health
POSB139 Predicting Quality of Life through Changes in Menstrual Blood Loss in Patients with Uterine Fibroids
2022 · M Lilja, O Frisell, et al. · Value in Health
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study
2022 · Lauppe, Rosa, Nilsson, Fredrik O. L., et al. · Figshare
246P Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study
2021 · A. Valachis, H. Lindman, et al. · Annals of Oncology
PDF
PRO56 The Epidemiology of Transthyretin Amyloid Cardiomyopathy in Sweden
2020 · R. Lauppe, J. Liseth Hansen, et al. · Value in Health
PDF
PUK12 Using Real-World DATA to Improve the Accuracy of Economic Models; Experience from the Swedish Renal Register
2020 · J.J. Carrero, M. Andersson-Franko, et al. · Value in Health
PDF
OP407 Network Meta-Analysis Of Prolonged Release Calcifediol And Paricalcitol
2020 · Joel Gunnarsson, Rosa Lauppe, et al. · International Journal of Technology Assessment in Health Care
Indirect Comparison of Treatments for Secondary Hyperparathyroidism Through a Network Meta-Analysis
2020 · Joel Gunnarsson, Rosa Lauppe, et al. · Journal of the American Society of Nephrology
Meta-Analysis of the Impacts of Supplementation with Nutritional Vitamin D on Mineral and Bone Markers in Non-Dialysis CKD
2020 · Joel Gunnarsson, Guiseppe Cianciolo, et al. · Journal of the American Society of Nephrology
Puk3 Treatment Effects in Secondary Hyperparathyroidism in Non-dialysis Chronic Kidney Disease: a Systematic Literature Review
2019 · J. Gunnarsson, R. Lauppe, et al. · Value in Health
PDF
Pcn61 a Freely Available Generic Cost-effectiveness Model in Oncology for Early-stage Decision Making
2019 · R. Lauppe, K. Geale, et al. · Value in Health
PDF
Puk6 a Cost-effectiveness Model for Secondary Hyperparathyroidism in Non-dialysis Chronic Kidney Disease
2019 · M. Lilja, R. Lauppe, et al. · Value in Health
PDF
Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark
2017 · R Lauppe, P Carlqvist, et al. · Value in Health
PDF
Works count: 24
Citation count: 205
H-index: 6
I10-index: 5
Year
Topic
Type